Chimin

Wallstreetcn · Apr 2 at 12:43 AM

China's A-share pharmaceutical industry chain continues to strengthen, with Chimin and CMC hitting the daily limit, following TJPC, YIBAI PHARMACEUTICAL, and PKU HEALTHCARE also hitting the daily limit. Previously, Huaren Health, Baheal Medical, SYPM, INNOSTIC, and HRPC, among other stocks, rose more than 5%

Zhitong · Oct 31, 2025 at 04:53 AM

Chimin: Plans to repurchase shares worth 100 million to 200 million yuan, with a total repurchase of 12.089 million yuan already completed

Zhitong · Sep 30, 2025 at 03:11 AM

Chimin disclosed the progress of its share repurchase, having repurchased a total of 2.0055 million shares

Zhitong · Sep 11, 2025 at 07:01 AM

Chimin: Currently, the stock price trend is significantly diverging from the operating performance trend

Zhitong · Sep 10, 2025 at 09:20 PM

The concept of innovative drugs has rebounded, with Chimin gaining 6 limit-ups in 12 days, Staidson BioPharm rising over 7%, Hotgen increasing over 5%, and stocks like Medicilon, Cosunter, and BrightGene also seeing gains

Zhitong · Sep 4, 2025 at 04:21 AM

Chimin's shareholder Shuangge Group plans to reduce its holdings by no more than 3%